Catheter Precision VTAK
NYSE VTAK
$0.15 +0.00 (+0.00%)
At close: Oct 2, 2026 · 4:00 PM EDT

Catheter Precision (VTAK) Asset Writedowns and Impairment (2023)

Updated

Catheter Precision's Asset Writedowns and Impairment came in at $7 million for FY2025.

Analysis

Catheter Precision (VTAK) Asset Writedowns and Impairment (2023) Analysis & Trends

  • Per Business Quant, earlier years put Asset Writedowns and Impairment at $60.93 million in FY2023.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Thermo Fisher Scientific 242.18 Bn 221.33 Bn 4.88 Bn
2 Abbott Laboratories 168.71 Bn 139.79 Bn 7.27 Bn
3 Danaher 150.46 Bn 134.27 Bn 3.61 Bn
4 Intuitive Surgical 138.71 Bn 118.26 Bn 1.96 Bn
5 Medtronic 110.54 Bn 76.41 Bn 6.34 Bn
6 Stryker 105.66 Bn 91.78 Bn 4.50 Bn
7 Boston Scientific 61.74 Bn 56.75 Bn 3.85 Bn
8 Edwards Lifesciences 49.09 Bn 33.21 Bn 1.35 Bn
9 Becton Dickinson 48.16 Bn 45.31 Bn 2.32 Bn
10 Catheter Precision 415,116.02 -4.46 Mn 98,000.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2023 4.85 Mn
Mar 31, 2023 56.09 Mn
API Access

Catheter Precision Asset Writedowns and Impairment API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=asset-writedowns-and-impairment&ticker=VTAK&period=max&api_key=YOUR_API_KEY